Related content

Significant Difference in p53 and p21 Protein Immunoreactivity in HPV 16 Positive and HPV Negative Breast Carcinomas

By Hennig Elin M.   Kvinnsland Stener   Holm Ruth   Nesland Jahn M.  

Acta Oncologica, Vol. 38, Iss. 7, 1999-11 ,pp. : 931-938

Informa Healthcare

Access to resources Recommend Favorite

Promoter methylation of p16 and RASSF1A genes may contribute to the risk of papillary thyroid cancer: A meta-analysis

By Jiang JiaLi   Tian GuiLan   Chen ShuJiao   Xu Li   Wang HuiQin  

Experimental and Therapeutic Medicine, Vol. 10, Iss. 4, 2015-10 ,pp. : 1549-1555

Spandidos Publications

Access to resources Recommend Favorite

Detecting abnormal methylation of tumor suppressor genes GSTP1, P16, RIZ1, and RASSF1A in hepatocellular carcinoma and its clinical significance

By          

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2553-2558

Spandidos Publications

Access to resources Recommend Favorite

G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value*

By Cho N.H.   Lim S.Y.   Kim Y.T.   Kim D.   Kim Y.S.   Kim J.W.  

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 15-22

Elsevier

Access to resources Recommend Favorite

Abrogation of P53 function by transfection of HPV16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation

By Huang H.   Li C.-Y.   Little J. B.  

International Journal of Radiation Biology, Vol. 70, Iss. 2, 1996-08 ,pp. : 151-160

Informa Healthcare

Access to resources Recommend Favorite